NCT04572932View on ClinicalTrials.gov

Probiotics and Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

February 29, 2020

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

lactobacillus delbruekii

Comarsion between probiotics and one of the most widely used symptomatc treatment for IBS itopride hcl

Trial Locations (1)

Unknown

Tropical medicine department, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04572932 - Probiotics and Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter